The federal government will extend COVID-era telehealth flexibilities until December 2024, dramatically extending the runway for the Drug Enforcement Administration (DEA) to establish new rules for using telehealth and controlled substances.The DEA and U.S. Department of Health and Human Services released a new temporary rule on Oct. 6 after conducting two days of listening sessions […]
